Relay Therapeutics (RLAY) Long-Term Investments (2020 - 2025)
Historic Long-Term Investments for Relay Therapeutics (RLAY) over the last 6 years, with Q3 2025 value amounting to $504.9 million.
- Relay Therapeutics' Long-Term Investments fell 2653.83% to $504.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $504.9 million, marking a year-over-year decrease of 2653.83%. This contributed to the annual value of $657.0 million for FY2024, which is 835.92% up from last year.
- Per Relay Therapeutics' latest filing, its Long-Term Investments stood at $504.9 million for Q3 2025, which was down 2653.83% from $542.8 million recorded in Q2 2025.
- In the past 5 years, Relay Therapeutics' Long-Term Investments registered a high of $847.1 million during Q4 2022, and its lowest value of $387.9 million during Q3 2021.
- In the last 5 years, Relay Therapeutics' Long-Term Investments had a median value of $657.0 million in 2024 and averaged $627.5 million.
- Per our database at Business Quant, Relay Therapeutics' Long-Term Investments surged by 19423.17% in 2021 and then tumbled by 2842.24% in 2023.
- Relay Therapeutics' Long-Term Investments (Quarter) stood at $678.0 million in 2021, then rose by 24.95% to $847.1 million in 2022, then dropped by 28.42% to $606.4 million in 2023, then rose by 8.36% to $657.0 million in 2024, then fell by 23.16% to $504.9 million in 2025.
- Its Long-Term Investments stands at $504.9 million for Q3 2025, versus $542.8 million for Q2 2025 and $616.8 million for Q1 2025.